Sylvain Garciaz
- Hematology top 10%
- Acute Myeloid Leukemia Research 22
- Multiple Myeloma Research and Treatments 3
-
- Chronic Lymphocytic Leukemia Research 8
-
- CAR-T cell therapy research 6
-
- Lymphoma Diagnosis and Treatment 11
-
- Immune Cell Function and Interaction 6
-
- CNS Lymphoma Diagnosis and Treatment 6
-
- Histone Deacetylase Inhibitors Research 5
- Co-authors
- Norbert VeyDiane CosoRéda BouabdallahYves ColletteYosr HicheriColombe SaillardJean‐Marc Schiano de ColellaDidier Blaise
- Cited by
- HematologyGeneticsOncology
- Journals
- Nucleic Acids Research (1 paper)Journal of Clinical Oncology (4 papers)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- FranceUnited StatesAustralia
In The Last Decade
Sylvain Garciaz
42 papers receiving 321 citations
Peers
Comparison fields: 5 of 53
- Hematology 133
- Genetics 52
- Oncology 117
- Pathology and Forensic Medicine 69
- Immunology 64
Countries citing papers authored by Sylvain Garciaz
This map shows the geographic impact of Sylvain Garciaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvain Garciaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvain Garciaz more than expected).
Fields of papers citing papers by Sylvain Garciaz
This network shows the impact of papers produced by Sylvain Garciaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvain Garciaz. The network helps show where Sylvain Garciaz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sylvain Garciaz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 16 | |
| 5 | 2024 | 12 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 13 | |
| 9 | 2023 | 6 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 2 | |
| 12 | 2023 | 7 | |
| 13 | 2023 | 8 | |
| 14 | 2022 | 3 | |
| 15 | 2022 | 36 | |
| 16 | 2022 | 2 | |
| 17 | 2020 | 4 | |
| 18 | 2016 | 2 | |
| 19 | 2016 | 20 | |
| 20 | 2013 | 4 |
About Sylvain Garciaz
Sylvain Garciaz is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 46 papers that have together received 324 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (22 papers), Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (8 papers), CAR-T cell therapy research (6 papers), CNS Lymphoma Diagnosis and Treatment (6 papers), Immune Cell Function and Interaction (6 papers), Histone Deacetylase Inhibitors Research (5 papers) and Multiple Myeloma Research and Treatments (3 papers). The work is most often cited by research in Hematology (133 citations), Genetics (52 citations) and Oncology (117 citations). Sylvain Garciaz has collaborated with scholars based in France, United States and Australia. Frequent co-authors include Norbert Vey, Diane Coso, Réda Bouabdallah, Yves Collette, Yosr Hicheri, Colombe Saillard, Jean‐Marc Schiano de Colella, Didier Blaise, Bruno Chetaille and Sabine Fürst. Their work appears in journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.